What’s New? March 2021

This week is marking one year from the official launch of the SOPHiA DDM TM Homologous Recombination Deficiency (HRD) Solution,…

On Rare Disease Day, SOPHiA GENETICS celebrates and honors the strength, resilience, and positivity of real-life superheroes who inspire us…

February 15th has been globally acknowledged as the International Childhood Cancer Day, a day dedicated to raising awareness on childhood…

The advancement of genomic analysis technology revolutionizes breast cancer research, as it provides better breast tumor classifications, which then leads…

With over 1.3 million women worldwide diagnosed with gynaecological cancers in 2020, it’s more important now than ever to equip…

SOPHiA GENETICS is excited to announce the launch of SOPHiA DDM™ Dispatch, a new way for our SOPHiA GENETICS Integrated…

SOPHiA GENETICS is excited to celebrate Clinical Trials Day. This blog dives a little deeper into the history of clinical…

Every person is unique. We can clearly see this within the more than one million genomic profiles from 70 different…

Third party sequencing services can enable increased access to NGS testing, but if institutions do not receive access to the…

SOPHiA GENETICS has reached a major milestone on a global scale by analyzing one million genomic profiles.

The field of precision medicine continues to evolve but remains steadfast in its goal to provide the right treatment to…

Larger panels may cast wider nets, but optimization with patented algorithms through our universal platform gives more actionable insights without…